Astelin nasal spray

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved November 1996

Specific Treatments:

seasonal allergic rhinitis

Find Related Trials for The Following Conditions

General Information

Astelin nasal spray has been approved for the treatment of symptoms associated with seasonal allergic rhinitis.

It offers a valuable treatment option for the estimated 20-40 million Americans who suffer from seasonal allergic rhinitis, the fifth most common chronic illness that causes millions of lost work days and significant discomfort for the sufferer.